Genes encoding eglin C mutants
US5180667A · kind A · utility
2Cited by
2References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 11, 1991 |
| Grant date | Jan 19, 1993 |
| Priority date | — |
| Expiry date | Oct 11, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A40/146
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
DNA encoding novel eglin mutants that differ from the natural eglins B and C by the replacement of amino acids in the region of the active center (amino acid 45) by other amino acids are provided. The mutants, which are produced by recombinant genetic engineering, have valuable pharmacological properties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.